Results 151 to 160 of about 12,625 (176)

Nirmatrelvir–ritonavir compared with other antiviral drugs for the treatment of COVID‐19 patients: A systematic review and meta‐analysis

Journal of Medical Virology, 2023
Fangyuan Tian, Zhaoyan Chen
exaly  

“Saving lives with nirmatrelvir/ritonavir one transplant patient at a time”

Transplant Infectious Disease, 2023
Katherine A Belden, Sarah Yeager, Maria P Martinez Cantarin   +2 more
exaly  

Simultaneous quantification of nirmatrelvir and ritonavir by LC-MS/MS in patients treated for COVID-19

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2022
Jens Martens-Lobenhoffer, Jan T Kielstein   +1 more
exaly  

Simultaneous determination of nirmatrelvir and ritonavir in human plasma using LC–MS/MS and its pharmacokinetic application in healthy Chinese volunteers

Biomedical Chromatography, 2022
Chenxi Liu, Min Song, Taijun Hang
exaly  

Carfilzomib/nirmatrelvir+ritonavir

Reactions Weekly, 2023
openaire   +1 more source

Nirmatrelvir+ritonavir/tozinameran

Reactions Weekly, 2023
openaire   +1 more source

A model-based pharmacokinetic assessment of drug–drug interaction between tacrolimus and nirmatrelvir/ritonavir in a kidney transplant patient with COVID-19

Drug Metabolism and Pharmacokinetics, 2023
Takeshi Tomida, Kotaro Itohara, Kazuhiro Yamamoto   +2 more
exaly  

Nirmatrelvir/ritonavir and pharmacovigilance data

The International Journal of Tuberculosis and Lung Disease
S, Lassan, M, Gocova, I, Solovic, T, Tesar, Z, Motesicka, M, Lassanova   +5 more
openaire   +2 more sources

Supratherapeutic Tacrolimus Concentrations With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients Requiring Hospitalization: A Case Series Using Rifampin for Reversal

Open Forum Infectious Diseases, 2022
Kristin E Mondy, Alexander L Chu
exaly  

Nifedipine/nirmatrelvir+ritonavir

Reactions Weekly, 2023
openaire   +1 more source